Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to USD 3.335 billion in Stock and…
Biocon Biologics, on Sunday, announced that it has entered into a definitive agreement with its partner Viatris. As per the agreement, Biocon Biologics Ltd. (BBL) will acquire Viatris’…
Read More...
Read More...